Case Analysis: Sycamore Pharmaceuticals
ABS 415 Leadership & Ethics
In this case, Sycamore Pharmaceuticals had lied about how effective their medication is in treating Crohn’s Disease and Lupus. Sycamore Pharmaceuticals hid the results of numerous studies that had unfavorable results. John Blake, an employee of Sycamore Pharmaceuticals, is now faced with the decision of whether or not to be honest with the Food and Drug Administration about his knowledge and involvement in these events.
I would advise John Blake to be honest with the Food and Drug Administration (FDA) as it is the only ethical thing to do. The possible consequences of disclosing information to the FDA are that Blake may be reprimanded or lose his job, Sycamore Pharmaceuticals may face legal consequences for its unethical behavior and Blake might not receive a bonus at the end of the quarter. However the rewards for being honest and telling the FDA what he knows far outweigh those possible consequences. For being honest, Blake could expect to receive such rare treasures as piece of mind and the knowledge that he is a good and ethical human being. Along with the psychological wellbeing that comes from being a good and decent person, Blake will most likely have an easy time finding a new job if he chooses to leave Sycamore Pharmaceuticals as he will have gained respect among his peers for acting ethically.
In addition to the risks and rewards of being honest, there are parallel risks and rewards for lying to the FDA. These include possible legal consequences, ranging from fines to jail time. It will take some courage for Blake to reveal his knowledge of and involvement with the scientific studies. To remain ethical and honest, even while under stress, is a true test of an individual’s character. For John Blake, this would be the time to call upon any sources of support or courage that he has. If Blake believes in a God or higher power, this would be a time in which...